SANUWAVE Health SNWV 深 沪
等待开盘 05-19 09:30:00 美东时间
16.86
+0.010
+0.06%
华盛通- 最 高17.46
- 今 开16.85
- 成交量 8.80万股
- 最 低 16.77
- 昨 收 16.85
- 总市值 1.45亿
- 52周最高 46.585
- 市盈率 静 41.32
- 换手率 1.02%
- 52周最低 15.355
- 委 比 -54.44%
- 总股本 859.90万
- 历史最高 46.585
- 量 比 0.49
- 振 幅 4.09%
- 历史最低 15.355
- 每 手 1
- 风险率 6.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SANUWAVE Health Inc Reports Q1 2026 Results: Full Earnings Call Transcript
SANUWAVE Health Inc (OTC:SNWV) released first-quarter financial results and hos...
05-13 21:51
SANUWAVE Health Sees Q2 Sales $11.100M-$11.600M
SANUWAVE Health (NASDAQ:SNWV) sees Q2 sales of $11.100 million-$11.600 million.
05-13 05:59
SANUWAVE Health Affirms FY2026 Sales Guidance of $51.000M-$55.000M
SANUWAVE Health (NASDAQ:SNWV) affirms FY2026 sales outlook from $51.000 million-$55.000 million to $51.000 million-$55.000 million.
05-13 05:59
SANUWAVE Health Q1 EPS $(0.17) Misses $(0.05) Estimate, Sales $9.619M Miss $9.630M Estimate
SANUWAVE Health (OTC:SNWV) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.05) by 240 percent. This is a 76.39 percent increase over losses of $(0.72) per share from the
05-13 05:08
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
Sanuwave Health Expects Q1 2026 Revenue In The Range Of $9.6M To $9.7M , An Increase Of 3-4% Over Q1 2025
Sanuwave Health, Inc. (the "Company" or "Sanuwave") (NASDAQ:SNWV), a leading provider of FDA-approved directed energy systems used in advanced wound care, today announced that revenues for the first quarter of 2026
04-17 05:03
美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
Roth Capital Reiterates Buy on SANUWAVE Health, Lowers Price Target to $47
Roth Capital analyst Kyle Bauser reiterates SANUWAVE Health (NASDAQ:SNWV) with a Buy and lowers the price target from $53 to $47.
03-31 02:03
SANUWAVE Health Q4 EPS $0.03 Misses $0.14 Estimate, Sales $13.094M Miss $13.250M Estimate
SANUWAVE Health (OTC:SNWV) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.14 by 77.78 percent. This is a 102.7 percent increase over losses of $(1.11) per share from the
03-27 04:40
